Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQuartix Tech Regulatory News (QTX)

Share Price Information for Quartix Tech (QTX)

Share Price is delayed by 15 minutes
Get Live Data
262.50    -2.50 (-0.94%)
Bid:
260.00
Ask:
265.00
Spread: 5.00 (1.923%)
Market Cap: £127.20m
QTX Live PriceLast checked at - London Stock Exchange

Intraday Quartix Tech Share Chart

Trading Statement

7 Apr 2025 07:00

RNS Number : 7892D
Quartix Technologies PLC
07 April 2025
 

 

Quartix Technologies plc

 

("Quartix", "the Group" or "the Company")

 

Trading Statement

 

Quartix Technologies plc, a leading supplier of subscription-based vehicle tracking systems, software and services, is pleased to provide the following trading statement, covering the first three months of 2025 ("Q1"). 

The Group has made a very good start to the year, with new subscriptions, customer acquisition and growth in ARR showing very strong progress. Quartix is confident of achieving market expectations for the year1 and continues to make improvements in its financial performance. With the exception of the inflationary pay rise given to staff effective 1 January 2025, overhead levels are broadly in line with those for H2 2024. Free cashflow for Q1 is expected to have been £1.3m, and this has increased net cash to £4.4m.

Additionally, the Company announces that its registered office will be changing on 17 April 2025 to One Cambridge Square, Cambridge, CB4 0AE.

Annualised Recurring Revenue ("ARR")

ARR is the key forward-looking measure of growth for the Company and an important indicator of shareholder value. ARR reported by the Company relates solely to committed software subscription revenues and does not include other service revenues which may recur.

The Company's ARR increased by £2.0m during Q1 to £34.2m, representing an increase of 21% over the ARR growth achieved in the same period in 2024. Of this growth, just over £0.9m was derived from new business. On a trailing-twelve-month ("TTM") basis ARR has grown by £3.8m, or 13%.

Price indexation has now been incorporated in virtually all customer contracts and is added to ARR at the point of the first invoice following each anniversary for each customer. Approximately 75% of the total impact of this indexation for 2025 occurred in Q1 (2024: 85%).

Net revenue retention ("NRR") on a TTM basis increased slightly to 96.3% in Q1. Further improvement in this measure is targeted.

Measures of ARR and ARR growth are calculated on a constant-currency basis2.

Customer acquisition

New customer acquisition in Q1 increased by 18% to 2,206 new customers and new subscriptions increased by 19% to 22,102. Both figures are quoted in comparison with the same three-month period in 2024.

On a TTM basis, the customer base increased by 10% to 31,040, and the total subscription base increased by 12% to 310,701.

The key metrics for the Group are shown below:

Country

ARR (£m)

% Growth (TTM)

Subscription Base (units)

% Growth (TTM)

Customer Base

% Growth (TTM)

New Subscriptions (units)

% Growth (Q1)

New Customers Acquired

% Growth (Q1)

UK/EI

18.78

+9%

161,241

+8%

11,837

+4%

8,868

+24%

492

+16%

France

8.87

+14%

84,283

+16%

9,439

+9%

7,139

+14%

683

+2%

USA

3.32

+7%

29,469

+1%

3,915

+2%

2,066

+41%

268

+52%

Italy

1.47

+53%

15,787

+43%

2,507

+42%

1,944

+16%

342

+31%

Spain

1.00

+40%

12,279

+39%

2,232

+32%

1,305

+19%

273

+26%

Germany

0.72

+63%

7,097

+42%

1,031

+35%

762

-17%

146

+17%

Other

0.03

545

79

18

2

Total

34.19

+13%

310,701

+12%

31,040

+10%

22,102

+19%

2,206

+18%

 

Tariffs

Quartix trades in the USA from an incorporated local subsidiary, Quartix Inc., which imports tracking systems used for new installations from Quartix Ltd in the UK. This hardware supply represents a small element of the Company's business, so tariff costs are expected to be modest at this stage, but further detailed review of this is underway.

4G upgrade

Progress on the 4G upgrade programme in France is progressing according to plan. A more detailed update will be provided in July.

MelloMonday

Quartix will, this evening (7th April) be attending MelloMonday, which is to be held as a webinar starting at 5:00pm and taking place via Zoom. Andy Walters, Executive Chairman, will be presenting to webinar participants at 6:30pm and taking questions. Investors may register here for a free ticket with the code SHFREE. The recording will be sent out to all registrants within 48 hours of the event.

Andy Walters, Executive Chairman of Quartix, commented:

"We have made a very strong start to 2025 and progress in each of our markets has been good. Annualised subscription revenues rose by 13% to £34m in the 12 months from April 2024 and both our order backlog and rate of new customer acquisition are significantly ahead of those at this point last year. We are achieving record levels of performance on most business measures. Notwithstanding any unexpected impact of a potential trade war, we are confident of meeting market expectations for 2025 and look forward to the rest of the year and the future with confidence ."

 

Notes:

1 The Company believes that market expectations for 2025 were, prior to this announcement, revenue £36.0m, Adjusted EBITDA £7.2m and free cashflow of £3.5m.

2 Comparisons made on the basis of constant-currency measurements are based on closing exchange rates applicable at 31/3/2025 of $1.292 and €1.194 to pounds sterling.

 

 

For further Information please contact:

Quartix (www.quartix.com)

Andrew Walters, Executive Chairman

Sally Morton, Company Secretary

 

01686 806 663

Cavendish Capital Markets Limited (Nominated Adviser and Broker)

Matt Goode / Seamus Fricker / Trisyia Jamaludin (Corporate Finance)

Sunila de Silva (Equity Capital Markets)

020 7200 0500

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFZGGDKDMGKZM
Date   Source Headline
2nd Jun 202612:17 pmRNSDirector/PDMR Shareholding
22nd Apr 20265:20 pmRNSResult of AGM
22nd Apr 20267:00 amRNSTrading Statement
8th Apr 202612:16 pmRNSDirector/PDMR Dealing, TVR & Investor Webinar
25th Mar 20267:00 amRNSFinal Results
20th Mar 20264:18 pmRNSNotice of Results
23rd Feb 20267:00 amRNSNotice of Results
11th Feb 20267:00 amRNSFRC Review, Accounting Policy & Notice of Results
8th Jan 20267:00 amRNSTrading Update
15th Dec 20255:47 pmRNSDirector/PDMR Shareholding
18th Nov 20252:15 pmRNSHolding(s) in Company
27th Oct 202512:49 pmRNSDirector/PDMR Shareholding
6th Oct 20255:37 pmRNSGrant of Options
6th Oct 20257:01 amRNS-RMelloMonday Investor Webinar
6th Oct 20257:00 amRNSTrading Statement
24th Jul 20257:00 amRNSInterim Results
3rd Jul 20257:00 amRNSTrading Statement
7th Apr 20257:00 amRNSTrading Statement
31st Mar 20253:52 pmRNSDirector/PDMR Shareholding
31st Mar 20251:30 pmRNSResult of AGM
31st Mar 20257:00 amRNSAGM Trading Statement
3rd Mar 20257:00 amRNSFinal Results
13th Feb 202510:00 amRNSInvestor Presentation via Investor Meet Company
13th Jan 20257:00 amRNSTrading Statement
15th Oct 20247:00 amRNSTrading Statement
28th Aug 202410:58 amRNSDirector/PDMR Shareholding
29th Jul 20247:00 amRNSInterim Results
8th Jul 20247:00 amRNSTrading Statement
15th May 20246:24 pmRNSGranting of Options
27th Mar 20244:00 pmRNSResult of AGM
27th Mar 20247:00 amRNSAGM Trading Statement and Directorate Change
4th Mar 20247:00 amRNSFinal Results
19th Feb 20247:00 amRNSDirectorate Changes
24th Jan 20245:45 pmRNSHolding(s) in Company
23rd Jan 20245:00 pmRNSDirector/PDMR Shareholding - Replacement
23rd Jan 20241:09 pmRNSDirector/PDMR Shareholding
17th Jan 20243:51 pmRNSHolding(s) in Company
17th Jan 20241:45 pmRNSHolding(s) in Company
9th Jan 20247:00 amRNSTrading Statement
18th Dec 202311:45 amRNSHolding(s) in Company
11th Dec 20237:00 amRNSKonetik update
28th Nov 20237:00 amRNSDirectorate Changes
10th Nov 20234:01 pmRNSDirector/PDMR Shareholding
11th Oct 20237:00 amRNSBoard Changes - Replacement
10th Oct 20235:00 pmRNSBoard Changes
6th Oct 20237:00 amRNSTrading Update
26th Sep 20237:00 amRNSDirectorate Change
21st Sep 202311:00 amRNSDirector/PDMR Shareholding
15th Sep 20237:00 amRNSAcquisition of Konetik GmBH
3rd Aug 20233:50 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.